Add Company
Join Now

Depixus Revenue and Competitors

License our Company Data API

Paris, France

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Depixus's estimated annual revenue is currently $11.5M per year.(i)
  • Depixus's estimated revenue per employee is $191,167

Employee Data

  • Depixus has 60 Employees.(i)
  • Depixus grew their employee count by -2% last year.

Depixus's People

NameTitleEmail/Phone
1
Chief Business OfficerReveal Email/Phone
2
VP EngineeringReveal Email/Phone
3
Senior Data ScientistReveal Email/Phone
4
Data ScientistReveal Email/Phone
5
Software QAReveal Email/Phone
6
Research And Development ScientistReveal Email/Phone
7
Ingénieur R&DReveal Email/Phone
8
BiophysicistReveal Email/Phone
9
Ingénieur seniorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M695%N/AN/A
#2
$19.5M126-2%N/AN/A
#3
$36.3M23422%N/AN/A
#4
$19.7M127-17%N/AN/A
#5
$14.3M920%$179.5MN/A
#6
$49.4M1961%€201.1MN/A
#7
$44.5M287-3%N/AN/A
#8
$7.6M49N/AN/AN/A
#9
$6.4M41N/AN/AN/A
#10
$17.2M111-15%N/AN/A
Add Company

What Is Depixus?

Depixus (formerly PicoSeq) is undertaking commercial development of a disruptive new technology for the fast, accurate, and inexpensive extraction of sequence and epigenetic information from long individual molecules of DNA and RNA. Our MAGNA technology goes beyond decoding the static genetic code to reveal the dynamics of the genome that control health and disease.

keywords:N/A

N/A

Total Funding

60

Number of Employees

$11.5M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Depixus News

2022-03-22 - Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug ...

NEW YORK – Depixus, a startup with operations on both sides of the English Channel, is working on commercializing technology that it says...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.2M6013%N/A
#2
$10.7M60-6%N/A
#3
$9.5M60-14%N/A
#4
$5.3M6036%N/A
#5
$15.8M6025%N/A